Par Pharmaceutical Companies, Inc.
-
CHICAGO -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1...
-
CHICAGO -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1...
-
WOODCLIFF LAKE -- Par Pharmaceutical Companies Inc. announced Tuesday that it has acquired rights to three products from Israeli drug firm Teva Pharmaceuticals for an undisclosed amount.
Par will own the application for federal approval of a generic version of Actiq, a drug used to treat pain in cancer patients, as well as the generic version of Amrix, a muscle relaxant. It will also own the U.S. rights to market modafinil tablets, the generic version of Provigil, which treats sleep disorders.
-
PHILADELPHIA -- The law firm of Spector, Roseman & Kodroff, P.C. announces that a securities class action lawsuit was commenced in the United States D...
-
Location: Spring Valley, N.Y.
Business: Generic pharmaceuticals
-
...The listing for each transaction includes the transaction number and the parties to the tran... G Par Pharmaceutical Companies,. ...
-
DUBLIN, Ireland -- The Par Pharmaceutical Companies, Inc. (NYSE:PRX) Corporate Conference Call took place on 28-Feb-06 8:00am ET.
The Co. reported t...
-
...v. PAR PHARMACEUTICAL COMPANIES, INC., a Delaware Corporation, aka. and/...
-
WASHINGTON -- The law firm Cohen, Milstein, Hausfeld & Toll, P.L.L.C. has filed a lawsuit in the United States District Court for the District of New ...
-
CONSHOHOCKEN, Pa. -- Goldman Scarlato & Karon, P.C., a law firm with offices in Pennsylvania and Ohio, announces that a lawsuit has been filed in the ...